No Data
Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger
Poolbeg Pharma in Talks With Hookipa for Potential Combination
Express News | Poolbeg Pharma: Non-Binding Discussions for an All-Share Acquisition by HOOKIPA of Poolbeg
HOOKIPA Pharma Inc. (NASDAQ:HOOK) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
HOOKIPA Pharma Cut to Sector Perform From Outperform by RBC Capital
RBC Downgrades HOOKIPA Pharma to Sector Perform From Outperform, Slashes Price Target to $2 From $48, Keeps Speculative Risk
SMS1313 : How to see through the future
Mangkawat OP SMS1313 : just see the profil. it write target $7 .